potassium channel modulators (Novo Nordisk)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepotassium channel modulators (Novo Nordisk)

Drug Alias NameKATP channel modulators (Novo Nordisk)diazoxide analogs (Novo Nordisk)MCC-134 derivatives (Novo Nordisk)NNC-55-0557

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPotassium channel modulators

TargetsPotassium channel

Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNovo Nordisk A/S

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNovo Nordisk A/S

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

ATC CodeN/A